pI: 6.4224 |
Length (AA): 444 |
MW (Da): 50443 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 429 | 3ig5 (A) | 2 | 483 | 35.00 | 0 | 1 | 1.19206 | 0.74 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128698)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_I002580 | glutamate-cysteine ligase catalytic subunit, putative |
Brugia malayi | Bm1_09550 | glutamate--cysteine ligase |
Candida albicans | CaO19.12526 | similar to S. cerevisiae GSH1 (YJL101C) |
Candida albicans | CaO19.5059 | similar to S. cerevisiae GSH1 (YJL101C) |
Caenorhabditis elegans | CELE_F37B12.2 | Protein GCS-1 |
Dictyostelium discoideum | DDB_G0284651 | gamma glutamylcysteine synthetase |
Drosophila melanogaster | Dmel_CG2259 | Glutamate-cysteine ligase catalytic subunit |
Echinococcus granulosus | EgrG_000800600 | glutamate cysteine ligase catalytic subunit |
Echinococcus multilocularis | EmuJ_000800600 | glutamate cysteine ligase, catalytic subunit |
Giardia lamblia | GL50803_16001 | Glutamate-cysteine ligase |
Homo sapiens | ENSG00000001084 | glutamate-cysteine ligase, catalytic subunit |
Leishmania braziliensis | LbrM.18.1700 | gamma-glutamylcysteine synthetase, putative |
Leishmania donovani | LdBPK_181660.1 | gamma-glutamylcysteine synthetase, putative |
Leishmania infantum | LinJ.18.1660 | gamma-glutamylcysteine synthetase |
Leishmania major | LmjF.18.1660 | gamma-glutamylcysteine synthetase, putative |
Leishmania mexicana | LmxM.18.1660 | gamma-glutamylcysteine synthetase, putative |
Loa Loa (eye worm) | LOAG_06492 | glutamate-cysteine ligase |
Mus musculus | ENSMUSG00000032350 | glutamate-cysteine ligase, catalytic subunit |
Neospora caninum | NCLIV_032550 | gamma-glutamylcysteine synthetase, putative |
Plasmodium berghei | PBANKA_0819800 | gamma-glutamylcysteine synthetase |
Plasmodium falciparum | PF3D7_0918900 | gamma-glutamylcysteine synthetase |
Plasmodium knowlesi | PKNH_0716900 | gamma-glutamylcysteine synthetase, putative |
Plasmodium vivax | PVX_099360 | gamma-glutamylcysteine synthetase, putative |
Plasmodium yoelii | PY01606 | gamma-glutamylcysteine synthetase-related |
Saccharomyces cerevisiae | YJL101C | glutamate--cysteine ligase |
Schistosoma japonicum | Sjp_0005910 | ko:K01919 glutamate--cysteine ligase [EC6.3.2.2], putative |
Schistosoma mansoni | Smp_013860 | glutamate-cysteine ligase |
Schmidtea mediterranea | mk4.001058.05 | Glutamate-cysteine ligase |
Schmidtea mediterranea | mk4.001058.04 | GlutamateALQ-cysteine ligase |
Trypanosoma brucei | Tb927.10.12370 | gamma-glutamylcysteine synthetase |
Trypanosoma congolense | TcIL3000_10_10590 | gamma-glutamylcysteine synthetase, putative |
Trypanosoma cruzi | TcCLB.507787.100 | gamma-glutamylcysteine synthetase, putative |
Trypanosoma cruzi | TcCLB.507625.99 | gamma-glutamylcysteine synthetase, putative |
Toxoplasma gondii | TGME49_232590 | glutamate-cysteine ligase, catalytic subunit domain-containing protein |
Theileria parva | TP03_0084 | gamma-glutamylcysteine synthetase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.12370 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.12370 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.12370 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.12370 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F37B12.2 | Caenorhabditis elegans | larval lethal | wormbase |
TGME49_232590 | Toxoplasma gondii | Probably non-essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium falciparum | gamma-glutamylcysteine synthetase | Compounds | References |
Homo sapiens | glutamate-cysteine ligase, catalytic subunit | Compounds | References |